Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
The New England journal of medicine · 2024 · 266 citations · Anjali Tiku Owens
Transplantation Outcomes with Donor Hearts after Circulatory Death.
The New England journal of medicine · 2023 · 293 citations · Maryjane Farr
International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024 · 179 citations · Maryjane Farr
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.
Journal of the American College of Cardiology · 2022 · 325 citations · Anjali Tiku Owens
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
Circulation · 2023 · 250 citations · Kenneth B. Margulies
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy.
Nature · 2022 · 342 citations · Kenneth B. Margulies
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
Journal of the American College of Cardiology · 2023 · 175 citations · Anjali Tiku Owens
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM.
Circulation · 2025 · 62 citations · Anjali Tiku Owens
Fellowship · Philadelphia, PA
Sponsored by University of Pennsylvania Health System